Key facts
- This page summarizes Albert Bourla's Form 4 filing for PFIZER INC (PFE).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 01 Nov 2023, 18:18.
Albert Bourla - 31 Oct 2023 Form 4 Insider Report for PFIZER INC (PFE)
- Issuer symbol
- PFE
- Transaction date
- 31 Oct 2023
- Net transaction value
- +$520
- Form type
- 4
- Filing time
- 01 Nov 2023, 18:18:57 UTC
- Previous filing
- 16 Oct 2023
- Next filing
- 16 Nov 2023
- SEC filing
- View on sec.gov
- Signature
- Susan E. Grant, by power of atty., for Albert Bourla
SEC evidence
5 facts
Reporting owner
1 fact
Key filing fact
Albert Bourla filed Form 4 for PFIZER INC (PFE) on 01 Nov 2023.
Change
- Previous filing in this sequence was filed on 16 Oct 2023.
- Current net transaction value: +$520.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
PFE
transaction
Derivative
Phantom Stock Units SSP
Award
- Transaction value
- $520
- Shares
- +17
- Change %
- +0.01%
- Price
- $30.56
- Shares after
- 181,151
- Date
- 31 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17
- Exercise price
- Footnotes
- F1, F2
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each unit represents one phantom share of common stock. |
| F2 | These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |